10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).

Erttmann, R; Tafese, T; Berthold, F; Kerbl, R; Mann, J; Parker, L; Schilling, F; Ambros, P; Christiansen, H; Favrot, M; Kabisch, H; Hero, B; Philip, T

Erttmann, R; Tafese, T; Berthold, F; Kerbl, R; Mann, J; Parker, L; Schilling, F; Ambros, P; Christiansen, H; Favrot, M; Kabisch, H; Hero, B; Philip, T.

Affiliation

Erttmann R; Department of Pediatric Hematology, Universitätskinderklinik, Hamburg, Germany.

Eur J Cancer ; 34(9): 1391-7, 1998 Aug.

Article in En | MEDLINE | ID: mdl-9849422

Subject(s)

Mass Screening/standards; Neuroblastoma/prevention & control; Age Distribution; Biomarkers, Tumor; Child, Preschool; Europe; Genes, myc; Humans; Infant; Loss of Heterozygosity; Neuroblastoma/genetics; Ploidies; Prognosis; Risk Factors; Sensitivity and Specificity; Sex Distribution; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Mass Screening / Neuroblastoma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Child, preschool / Humans / Infant Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 1998 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links